Nurses Emerge as Key Players in Taming Targeted Cancer Therapy Side Effects
A scoping review of 14 studies finds that nurse-led education, continuity-of-care programs, and telehealth monitoring are the main strategies for ...
A scoping review of 14 studies finds that nurse-led education, continuity-of-care programs, and telehealth monitoring are the main strategies for ...
A 78-year-old woman developed hyperactive delirium with hallucinations and persecutory delusions during pembrolizumab therapy, and her symptoms fully resolved after ...
A case report describes cholestatic liver injury during atezolizumab therapy for EGFR-mutant combined small cell lung cancer, with AMA-M2 positivity ...
A real-world cohort study of 136 patients aged 65 and older found high rates of hospitalization and immune-related toxicity with ...
A retrospective single-center cohort found that acute pancreatitis during immune checkpoint inhibitor therapy was associated with treatment disruption and substantially ...
University of Pittsburgh researchers created a diet-based mouse model showing that fragile regulatory T cells, shaped by a Western-style diet ...
A prospective single-center cohort linked baseline thyroid autoantibodies and higher TSH to more immune-related thyroid dysfunction during advanced lung cancer ...
A case report from Gunma University describes severe autoimmune hemolytic anemia triggered by nivolumab plus ipilimumab for melanoma that resolved ...
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
A small exploratory study links distinct immature and inflammatory states of circulating high-density neutrophils to both resistance to immune checkpoint ...
A Barcelona case series and systematic review of 103 patients map the clinical features, treatment patterns, and high mortality of ...
A patient-level synthesis of 40 published cases shows that nivolumab-induced hypophysitis predominantly damages the pituitary's cortisol-regulating axis, responds well to ...
A large analysis of melanoma patients treated with immune checkpoint inhibitors finds that 12 percent develop significant neurotoxicity, often within ...
A large target trial emulation found that cancer patients on SSRIs while receiving immune checkpoint inhibitors had significantly lower two-year ...
An analysis of nearly half a million clinical trials and real-world data from over 91,000 patients reveals that immune-related side ...
A real-world study of 95 patients in Tokyo confirms that pembrolizumab combined with chemotherapy before and after surgery delivers event-free ...
A genomic study of 841 melanoma patients at NYU Langone Health found that underrepresented minority patients experienced significantly more immune ...
The ever-evolving landscape of cancer treatment is witnessing remarkable strides, particularly with the advent of immune checkpoint inhibitors (ICIs). These ...
In recent years, the treatment landscape for Merkel cell carcinoma (MCC), a rare yet aggressive form of skin cancer, has ...
Immunotherapy has revolutionized the treatment landscape for melanoma, particularly in the last decade. However, as the potential for these innovative ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.